US 10596260
Reoviruses having modified sequences
granted A61KA61K35/13A61K35/765
Quick answer
US patent 10596260 (Reoviruses having modified sequences) held by ONCOLYTICS BIOTECH INC. expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K35/13, A61K35/765, A61K45/06, A61P